Navigation Links
Science May Banish Bad Hair Days
Date:8/18/2008

Super close-up views of how strands interact could be key, researchers say

MONDAY, Aug. 18 (HealthDay News) -- Whether it's frizzy or flyaway, nearly everyone puts up with an unruly head of hair from time to time. Now scientists have trained their microscopes on hair to find out why it misbehaves -- and how to tame it.

In a new study, said to be the first of its kind, German researchers say they've gotten extreme-close-up views of how hair fibers interact. Their insights could lead to products that banish bad hair days for good, they say.

"At the moment, it is not known why hair feels good," explained study co-author Eva Max, a doctoral student in chemistry at the University of Bayreuth in Germany. That, in turn, makes it difficult to scientifically study hair care products, which make up a $60 billion industry worldwide.

In the new study, Max and colleagues explored the workings of hair with an atomic-force microscope and samples of Caucasian female hair. The study authors were scheduled to present their findings Aug. 17 at the American Chemical Society's national meeting, in Philadelphia.

According to the team, damage to hair causes scaly projections to protrude from hair fibers. These projections create friction with other fibers and make hair feel rough to the touch and hard to comb.

The researchers also found that electrical charges build up on hair, causing friction.

The next step is to figure out what happens to the hair when it's exposed to hair-care products such as shampoo and conditioner.

"There are several changes that take place at the same time when hair is exposed to hair care products, and it will help greatly to understand which of those changes is crucial for optimizing hair care," Max said. "If, for example, it would turn out that there is an optimum friction between single hairs for pleasant (touch), the molecular composition of hair-care products can be optimized to achieve this friction."

Steven Shiel, who studies hair at Proctor & Gamble, said the German research could help shed more light on how hair fibers interact and lead to better hair care products. "Those invisible-to-the-eye changes have a great impact on how the ingredients in the products affect the hair," he said.

Hair styling products have become more sophisticated in recent years, and this has much to do with science, said Shiel, an associate director with P&G Beauty.

"A lot of this is based on this fundamental understanding of hair's underlying structure and properties," he said. "Fundamentally understanding the hair structure is really important in terms of developing products that really deliver."

More information

Learn about hair loss and disease from the National Institutes of Health.



SOURCES: Eva Max, doctoral student, University of Bayreuth, Germany; Steven Shiel, Ph.D., associate director, Proctor & Gamble Beauty, Cincinnati; Aug. 17, 2008, American Chemical Society National Meeting, Philadelphia


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
2. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
3. Edwards Lifesciences to Present at the Bear Stearns 20th Annual Healthcare Conference
4. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
5. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
6. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
7. John B. Buse, MD, PhD of Chapel Hill, NC, Elected American Diabetes Association President, Medicine & Science
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. SAMHSA Announces First Science and Service Award Winners
10. Novavax CEO to Present at the 2007 UBS Global Life Sciences Conference
11. Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Science May Banish Bad Hair Days
(Date:9/19/2017)... Raton (PRWEB) , ... September 19, 2017 , ... ... the El Naturalista brand, developed by ACPG Laboratories, is coming soon to RonnieColemanNutrition.com. ... in Spain, and El Naturalista is a trusted, well-respected brand reliant on the ...
(Date:9/19/2017)... ... ... For decades doctors, nurses, and other healthcare providers have been trained to ... calculating their cardiovascular disease (CVD) risk in the next 10 years. , Imagine ... an estimated 10-year risk prediction! , Imagine if the weatherman says there is a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... with the Davidson Fellows Scholarship on September 27 at a reception in Washington ... Technology, Engineering, Mathematics, Literature and Music. , “I am honored to be a ...
(Date:9/19/2017)... ... September 19, 2017 , ... Emergency nursing expertise, skill ... Emergency Nurse (CEN®) certification according to a large-scale study announced today by ... conducted by the Human Resources Research Organization (HumRRO) in late 2016 and early ...
(Date:9/18/2017)... Bangkok, Thailand (PRWEB) , ... September 19, 2017 ... ... in Asia Pacific’s protein ingredient market , expected to grow at the ... Frost & Sullivan sharing the ‘Global Food Protein Trends & Growth Opportunities in ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Sept. 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting ... Rodman & Renshaw 19 th Annual Global Investment ... (12:25 p.m. Pacific time). The conference is being held at ...
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... JERUSALEM , Sept. 5, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has successfully concluded its meeting with the U.S. ... novel oral insulin formulation. ... that the regulatory pathway for submission of ORMD-0801, would ...
Breaking Medicine Technology: